[HTML][HTML] Research progress on the interactions between long non‑coding RNAs and microRNAs in human cancer
B Sun, C Liu, H Li, L Zhang, G Luo… - Oncology …, 2020 - spandidos-publications.com
Numerous types of molecular mechanisms mediate the development of cancer. Non‑coding
RNAs (ncRNAs) are being increasingly recognized to play important role in mediating the …
RNAs (ncRNAs) are being increasingly recognized to play important role in mediating the …
[HTML][HTML] Long non-coding RNAs are involved in alternative splicing and promote cancer progression
J Ouyang, Y Zhong, Y Zhang, L Yang, P Wu… - British Journal of …, 2022 - nature.com
Alternative splicing (AS) is a key process in which precursor RNAs produce different mature
RNAs, and the disorder of AS is a key factor in promoting cancer development. Compared …
RNAs, and the disorder of AS is a key factor in promoting cancer development. Compared …
LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) with the most
aggressive phenotype and poor overall survival. Using bioinformatics tools, we identified …
aggressive phenotype and poor overall survival. Using bioinformatics tools, we identified …
[HTML][HTML] RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
Q Li, Q Lai, C He, Y Fang, Q Yan, Y Zhang… - Journal of Experimental …, 2019 - Springer
Background Runt-related transcription factor 1 (RUNX1) plays the roles of an oncogene and
an anti-oncogene in epithelial tumours, and abnormally elevated RUNX1 has been …
an anti-oncogene in epithelial tumours, and abnormally elevated RUNX1 has been …
[HTML][HTML] cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway
G Huang, H Zhu, Y Shi, W Wu, H Cai, X Chen - PloS one, 2015 - journals.plos.org
Noncoding RNAs (ncRNAs) are the dominant product of eukaryotic transcription. These
products range from short microRNAs (miRNAs) to long intergenic noncoding RNAs …
products range from short microRNAs (miRNAs) to long intergenic noncoding RNAs …
[HTML][HTML] Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2
Y Wu, L Hu, Y Liang, J Li, K Wang, X Chen, H Meng… - Molecular Cancer, 2017 - Springer
Background Abnormal expression of numerous long non-coding RNAs (lncRNAs) has been
reported in esophageal squamous cell carcinoma (ESCC) recently, but the great majority of …
reported in esophageal squamous cell carcinoma (ESCC) recently, but the great majority of …
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma
W Cao, J Liu, Z Liu, X Wang, ZG Han, T Ji, W Chen… - Oral oncology, 2017 - Elsevier
Abstract Objective Long non-coding RNAs (lncRNAs) have important biological functions
and can be used as prognostic biomarkers in cancer. To identify a lncRNA prognostic …
and can be used as prognostic biomarkers in cancer. To identify a lncRNA prognostic …
A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) with a
poor prognosis. To date, the mechanism of TNBC's aggressive phenotype is still unclear …
poor prognosis. To date, the mechanism of TNBC's aggressive phenotype is still unclear …
[HTML][HTML] RUN (X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome
EJ Rozen, CD Ozeroff, MA Allen - Human Genomics, 2023 - Springer
Background RUNX1 is a transcription factor and a master regulator for the specification of
the hematopoietic lineage during embryogenesis and postnatal megakaryopoiesis …
the hematopoietic lineage during embryogenesis and postnatal megakaryopoiesis …
The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations
The process of alternative splicing (AS) is widely deregulated in a variety of cancers.
Splicing is dependent upon splicing factors. Recently, several long noncoding RNAs …
Splicing is dependent upon splicing factors. Recently, several long noncoding RNAs …